Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Capricor Therapeutics Ownership Summary


Capricor Therapeutics is owned by 19.64% institutional investors, 16.75% insiders, and 63.61% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.97% of CAPR shares. SPDR® S&P Biotech ETF is the top mutual fund, with 2.97% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCapricor Therapeutics19.64%16.75%63.61%
SectorHealthcare Stocks 57.43%9.41%33.16%
IndustryBiotech Stocks 69.02%8.92%22.06%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de2.97M8.97%$40.94M
Vanguard group2.28M6.88%$31.42M
Farallon capital management2.25M6.80%$31.06M
State street2.21M6.67%$30.48M
Blackrock1.63M5.19%$7.77M
Geode capital management879.47K2.66%$12.14M
Altium capital management lp714.00K2.16%$9.85M
Woodline partners lp629.93K1.90%$8.69M
Goldman sachs group294.77K0.89%$4.07M
Susquehanna group, llp281.30K0.85%$3.88M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Altium capital management lp714.00K2.79%$9.85M
Superstring capital management lp55.23K0.66%$762.16K
Black diamond financial277.74K0.57%$3.83M
Farallon capital management2.25M0.16%$31.06M
Adar1 capital management56.12K0.15%$774.46K
Ubs oconnor104.80K0.11%$1.45M
Eam investors38.28K0.07%$528.21K
Woodline partners lp629.93K0.06%$8.69M
Maven securities150.00K0.05%$2.07M
Pfm health sciences, lp54.36K0.05%$750.13K

Top Buyers

HolderShares% AssetsChange
Farallon capital management2.25M0.16%2.25M
State street2.21M0.00%1.70M
Blackrock1.63M0.00%1.25M
Blackrock funding, inc. /de2.97M0.00%1.22M
Vanguard group2.28M0.00%700.24K

Top Sellers

HolderShares% AssetsChange
Ikarian capital---300.00K
Superstring capital management lp55.23K0.66%-282.12K
Point72 asset management---250.20K
Advisor group6.30K0.00%-234.45K
Renaissance---137.50K

New Positions

HolderShares% AssetsChangeValue
Farallon capital management2.25M0.16%2.25M$31.06M
Woodline partners lp629.93K0.06%629.93K$8.69M
Black diamond financial277.74K0.57%277.74K$3.83M
Maven securities150.00K0.05%150.00K$2.07M
Kennedy capital management144.25K0.04%144.25K$1.99M

Sold Out

HolderChange
Federated hermes-68.00
Lazard asset management-69.00
Capital performance advisors llp-91.00
Yhb investment advisors-150.00
Signaturefd-393.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202440-57.45%6,498,502-22.35%193.07%32-42.86%3-72.73%
Sep 30, 20249438.24%8,369,32730.24%256.02%5633.33%11-26.67%
Jun 30, 2024687.94%6,426,23433.35%208.30%42-1566.67%
Mar 31, 20246357.50%4,818,91920.83%156.59%4290.91%912.50%
Dec 31, 2023408.11%3,988,123-27.56%153.27%2283.33%8-27.27%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
SPDR® S&P Biotech ETF1.35M2.97%10.22K
Vanguard Total Stock Mkt Idx Inv1.19M2.62%-
iShares Russell 2000 ETF956.40K2.10%-18.70K
Vanguard Institutional Extnd Mkt Idx Tr647.84K1.42%193.00
iShares Russell 2000 Growth ETF274.73K0.60%-324.00
Fidelity Small Cap Index261.86K0.58%-994.00
State St Russell Sm/Mid Cp® Indx NL Cl C235.69K0.52%-
Fidelity Extended Market Index232.38K0.51%66.05K
Vanguard Russell 2000 ETF162.50K0.36%-10.91K
State St Russell Sm Cap® Indx SL Cl I131.20K0.29%43.20K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 20, 2024Nippon Shinyaku Co Ltd-Buy$15.00M
Oct 12, 2023Musket David B-Buy$1.13K
Oct 10, 2023COLLIER EARL M JR-Buy$28.30K
Oct 09, 2023Musket David B-Buy$14.33K
Oct 06, 2023Auwaerter Paul Gisbert-Buy$14.20K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q31-
2024 Q2--
2024 Q1--

CAPR Ownership FAQ


Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 19.64%, followed by 16.75% insiders and 63.61% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 69.02%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock funding, inc. /de (2.97M shares, 8.97%), Vanguard group (2.28M shares, 6.88%), and Farallon capital management (2.25M shares, 6.80%). Together, they hold 22.65% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Altium capital management lp is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.79% of its assets in 714K Capricor Therapeutics shares, valued at 9.85M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

SPDR® S&P Biotech ETF is the top mutual fund holder of Capricor Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.35M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools